Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:6 publications

Grant number: 170654

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $511,268.73
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principle Investigator

    Pending
  • Research Location

    Canada, Americas
  • Lead Research Institution

    Institute for Medical Research (Mtl)
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The recent outbreak of the coronavirus COVID-19 pandemic clearly demonstrates how in today's age infectious agents can spread rapidly. Given the ability of individuals to travel across the globe infectious agents can reach pandemic/epidemic proportions quickly, as seen with SARS and MERS outbreaks. Such viral agents become infectious because of genetic alterations many times occurring in other animals and eventually can infect humans. There are no effective anti-viral agents nor have vaccines been developed. Thus during these outbreaks we can only rely on infection control measures. Such measures help control the spread of the disease but is dependent on verifying individuals who are infected and those who are not infected. Presently diagnosing COVID-19 infections is inadequate as the laboratory tests may take 24-48 hrs to be completed. Such time periods make infection control very difficult. In this proposal we discuss how a rapid testing and diagnosis be made in the order of minutes. We have developed a revolutionary methodology that would construct a diagnostic device which is small and portable, and even be battery operated. Our device would be a true point of care platform that would be used at the "first contact" between patient and health professional. Our point of care testing platform would give rapid result in minutes and would help enormously in infection control management of not only the current COVID-19 outbreaks but also future pathogenic viral outbreaks which are surely to happen.

Publicationslinked via Europe PMC

Last Updated:41 minutes ago

View all publications at Europe PMC

Scaling of ventral hippocampal activity during anxiety

Hippocampal networks support reinforcement learning in partially observable environments

Hippocampal contextualization of social rewards

Fear extinction relies on ventral hippocampal safety codes shaped by the amygdala.

Firing patterns of ventral hippocampal neurons predict the exploration of anxiogenic locations.

Central amygdala micro-circuits mediate fear extinction.